{"id":"metamfepramone","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"dimepropion","offLabel":[],"synonyms":["metamfepramone","dimethylpropion","metamfepyramone","N-Methylephedrone","MG 559","dimepropion"],"timeline":[],"approvals":[],"brandName":"Dimepropion","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your brain is a city with many different streets and intersections. Dimepropion helps to increase the flow of traffic on certain streets, allowing messages to be sent more quickly and efficiently. This can help to improve focus, attention, and energy levels, but it can also have negative effects if taken in excess.","oneSentence":"Dimepropion is a central nervous system stimulant that works by increasing the activity of certain neurotransmitters in the brain.","technicalDetail":"Dimepropion is a small molecule that acts as a central nervous system stimulant, likely through the inhibition of dopamine and norepinephrine reuptake, although the exact mechanism of action is unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3772","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METAMFEPRAMONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:36:30.793226","biosimilars":[],"competitors":[],"genericName":"metamfepramone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"006781","UNII":"04A0P12FH2","CHEBI":"CHEBI:134812","INN_ID":"1587","UMLSCUI":"C0066048","ChEMBL_ID":"CHEMBL2105245","PUBCHEM_CID":"71872","MESH_SUPPLEMENTAL_RECORD_UI":"C034349"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dimepropion, also known as Metamfepramone, is a small molecule drug with unknown target and drug class. It is currently owned by an unknown entity, and its commercial status is unclear. The drug is used to treat unknown indications, and its safety profile and pharmacokinetic properties are not well-documented. Further research is needed to fully understand the properties and uses of Dimepropion. As a result, it is not possible to provide a comprehensive summary of this drug at this time.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}